Category: Prostate Cancer
-
-
Better patient counseling needed on post-RP erectile function – – UrologyTimes
Acting on anecdotal evidence, Dr. Nelson and his co-authors, Peter Scardino, MD, and John P. Mulhall, MD, assessed the erectile function of 250 men average age, 59±8 years pre- and post-radical prostatectomy. Of the men with baseline erectile function scores ≥24 mild to no dysfunction, about one-third 32% regained function; however, well over half 60%…
-
Added Radiation to ADT May Improve Survival – Renal and Urology News
Men with locally advanced prostate cancer (PCa) have a better chance of survival when they add radiation therapy (RT) to their hormone therapy, according to research presented at the 52nd annual meeting of the American Society for Radiation Oncology. via Added Radiation to ADT May Improve Survival – Renal and Urology News. This is another…
-
Dutasteride Slows Prostate Cancer Progression – Renal and Urology News
ORLANDO—Dutasteride, a drug widely prescribed for treating benign prostatic enlargement, lowers the risk of prostate cancer PCa progression in men undergoing active surveillance for the disease, researchers concluded. via Dutasteride Slows Prostate Cancer Progression – Renal and Urology News. Dutasteride has been used for BPH and is thought to help reduce the risk of developing…
-
MedWire News – Oncology – PCA3 predicts prostate tumor volume and could indicate AS suitability
MedWire News: Prostate cancer patients urinary prostate cancer antigen 3 PCA3 scores are strongly indicative of tumor volume, and could be a useful marker of suitability for treatment with active surveillance AS, study findings show. via MedWire News – Oncology – PCA3 predicts prostate tumor volume and could indicate AS suitability. I have been using…
-
FDA committee votes down 5-ARIs for prostate cancer risk reduction – – UrologyTimes
“Although the REDUCE trial demonstrated a risk reduction in a large number of men, the committee chose to focus on a small number of high-grade cancers and determined that this class of drugs is inappropriate for prostate cancer risk reduction, even in the population of men with elevated PSA and previous negative biopsy,” added Dr.…
-
MedWire News – Oncology – MRI useful for detecting tumors in men with rising PSA, negative biopsies
MedWire News: Magnetic resonance imaging (MRI) may be useful for detecting potentially missed prostate tumors in men with rising prostate-specific antigen (PSA) levels but negative biopsies, suggest review findings. Nathan Lawrentschuk (University of Toronto, Ontario, Canada) and colleagues add that men wishing to initiate or remain on active surveillance (AS) may benefit from MRI by…
-
Prostate Cancer & Treatment
-
UroToday – Laparoscopic mesh herniorrhaphy: Impact on outcomes associated with radical retropubic prostatectomy
Source: Urotoday Eighteen patients with a prior LMH underwent RRP. Five of the 18 had bilateral LMH, with unilateral LMH in the remainder. Outcomes in this group were compared with 38 patients without prior LMH. There was no difference between the groups in terms of age, preoperative PSA, prostate size, preoperative Gleason score, or body…